Hospital Viamed Montecanal

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease4 trials

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Completed2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alector Inc.2 trials
• Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
• PRInnovation GmbH1 trial

Running trials

• Recruiting

  A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

  NCT05511363· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

  Contact: Antonio Oliveros-Cid, Site 2206

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting

Closed trials

• Completed

  Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

  NCT06182085· Phase 2· PRInnovation GmbH· Source

• Terminated

  A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

  NCT05744401· Phase 2· Alector Inc.· Source

• Completed

  A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

  NCT04592874· Phase 2· Alector Inc.· Source